The objective of this study was to understand PSA testing patterns for older prostate cancer patients during the three years prior to their PCa diagnosis, and whether receipt of screening PSA testing was associated with distant stage disease at diagnosis. This evidence concerns the gene KLK3 and prostate carcinoma.